[Thyroid anaplastic tumor: our experience].
We report our experience over the past 10 years in the treatment of thyroid anaplastic carcinoma analysing retrospectively 21 cases of surgical treatment (7 total thyroidectomies, 12 partial resection of the tumours and 2 biopsies). We consider the prognosis, which is invariably fatal, with no survival at 19 months and a mean survival of only 9 months, and assess the validity of a combined therapeutic approach (surgery + radiotherapy + chemotherapy) to increase survival and, above all, the patient's quality of life. The importance is stressed of through monitoring of risk factors consisting in concomitant or previous benign or malignant thyroid disease, considering total thyroidectomy to be necessary in principle for any variety of thyroid cancer. Lastly, we examine the survival trend in terms of residual disease and the presence or otherwise of remote metastases.
Urciuoli
Paolo
P
Dipartimento di Scienze Chirurgiche, Università La Sapienza, Viale Regina Elena, 324, 00161 Roma.
Ghinassi
Sabrina
S
Iavarone
Claudio
C
Peparini
Nadia
N
D'Orazi
Valerio
V
Gabatel
Riccardo
R
Pichelli
Daniele
D
Iachetta
Roberto Paolo
RP
Custureri
Filippo
F
D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D013964:Thyroid Neoplasms / Q000401:mortality / Q000601:surgery*